As of 2026, these are the milestones that ended broad GLP-1 compounding: Tirzepatide Shortage declared resolved on October 2, 2024 , and reaffirmed after a legal challenge on December 19, 2024
Like Qsymia, it is oral
Otten R, Padua RAP, Bunzel HA, Nguyen V, Pitsawong W, Patterson M, Sui S, Perry SL, Cohen AE, Hilvert D, Kern D (2020) How directed evolution reshapes the energy landscape in an enzyme to boost catalysis
P., Lund, F
Similar content being viewed by others Introduction Type 2 diabetes (T2D) is a complex disease that is characterized by elevated circulating glucose levels, which can lead to a significant reduction in the quality of life and severe complications such as kidney failure, amputations, and premature cardiovascular mortality 1,2
These disorders include Prediabetes or type 2 diabetes mellitus (DM2) Hypertension